Clinical Trials List
2012-11-01 - 2017-03-31
Phase III
Terminated5
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- - - Division of General Internal Medicine
- Sheng-chieh Chou Division of General Internal Medicine
- Jih-Luh Tang Division of General Internal Medicine
- Wen-Chien Chou Division of General Internal Medicine
- 林建廷 Division of General Internal Medicine
- 徐思淳 Division of General Internal Medicine
- HSIN-AN HOU Division of General Internal Medicine
- MING YAO Division of General Internal Medicine
- 李啟誠 Division of General Internal Medicine
- Chien-Yuan Chen Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Ya-Ping Chen Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
- Wu-Chou Su Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 張平穎 Division of Hematology & Oncology
- Tsu-Yi Chao Division of Hematology & Oncology
- TSU-YI CHAO Division of Hematology & Oncology
- 何景良 Division of Hematology & Oncology
- 戴明燊 Division of Hematology & Oncology
- 高偉堯 Division of Hematology & Oncology
- 黃子權 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Tung-Liang Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Jyh-Pyng Gau Division of Hematology & Oncology
- 曾成槐 Division of Hematology & Oncology
- Liang-Tsai Hsiao Division of Hematology & Oncology
- Jin-Hwang Liu Division of Hematology & Oncology
- Tzeon-jye Chiou Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
280 participants
